Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia.
Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia.
J Infect Dev Ctries. 2023 Feb 28;17(2):251-259. doi: 10.3855/jidc.17462.
Isolation of human respiratory syncytial virus (HRSV) from clinical samples and storage of isolates for long period remains a considerable problem. We describe in detail the optimized conditions of HRSV isolation and cultivation in three cell cultures HeLa, HEp-2, and Vero. HRSV was detected in 35.2% (166/471) specimens by real-time PCR from symptomatic infants and children up to 15 years from October 2017 to March 2018 in Russia. HRSV-positive samples were used for virus isolation in HeLa, HEp-2, and Vero cells in different manners (in monolayer or suspension). To optimize the conditions of HRSV cultivation, these cell cultures were treated or not with receptor-destroying enzyme (RDE). Ten isolates were successfully obtained by the way of infection of the suspension of cells with subsequent RDE treatment. Among them, several isolates induced the cytopathogenic effect (CPE) by the syncytium formation in both Hela and HEp-2 cell cultures. The genetic analysis revealed that the manners of isolation by using monolayer or suspension and subsequent RDE treatment did not influence the nucleotide and amino acid structures of obtained HRSVs. The CPE characteristics of obtained viruses were the same in HeLa, HEp-2, and Vero cell cultures, and were described as large syncytium up to 150 microns or more in size with the nuclei peripheral location and an optically bright zone in the center of the formation. We showed that infection of cell suspension with the subsequent RDE treatment increased the chance of HRSVs isolation from clinical samples.
从临床样本中分离人类呼吸道合胞病毒(HRSV)并长期储存分离株仍然是一个相当大的问题。我们详细描述了在三种细胞培养物(Hela、HEp-2 和 Vero)中优化的 HRSV 分离和培养条件。在 2017 年 10 月至 2018 年 3 月期间,我们从俄罗斯 15 岁以下的有症状婴儿和儿童的 471 份标本中通过实时 PCR 检测到 35.2%(166/471)的标本为 HRSV 阳性。将 HRSV 阳性样本用于在 HeLa、HEp-2 和 Vero 细胞中以不同方式(单层或悬浮液)进行病毒分离。为了优化 HRSV 培养条件,这些细胞培养物用或不用受体破坏酶(RDE)处理。通过感染细胞悬浮液并用随后的 RDE 处理的方式成功获得了 10 个分离株。其中,有几个分离株在 Hela 和 HEp-2 细胞培养物中通过形成合胞体诱导了细胞病变效应(CPE)。遗传分析表明,使用单层或悬浮液进行分离的方式以及随后的 RDE 处理不影响获得的 HRSV 的核苷酸和氨基酸结构。获得的病毒的 CPE 特征在 HeLa、HEp-2 和 Vero 细胞培养物中是相同的,描述为大小可达 150 微米或更大的大合胞体,其细胞核位于周边位置,形成体的中心有一个光学亮区。我们表明,用随后的 RDE 处理感染细胞悬浮液增加了从临床样本中分离 HRSV 的机会。